Immunization advisory bodies recommend that all infants, adolescents, and high-risk adults receive the hepatitis B vaccine for protection from serious liver disease, including cirrhosis and ...
Neuromyelitis optica spectrum disorder (NMOSD) and related demyelinating diseases, including myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), represent a spectrum of autoimmune ...
A comprehensive meta-analysis of 18 studies, involving more than 1 million patients with autoimmune diseases, has revealed a 36% higher risk of central nervous system (CNS) inflammatory diseases in ...
Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced ...
WASHINGTON, DC — Age-related neurodegenerative disorders — motor neuron diseases, demyelinating diseases, Alzheimer’s disease, and other proteinopathies — are at an “inflection point,” said researcher ...
The breakdown of methylmalonic acid yields fatty acids necessary for the formation of myelin. Has anyone measured the level of methylmalonic acid in demyelinating diseases, such as multiple sclerosis ...
Folia Health today announced a collaboration with argenx to launch a first-of-its-kind, at-home observational real-world evidence initiative supporting individuals living with chronic inflammatory ...
(RTTNews) - argenx SE (ARGX) announced that Japan's Ministry of Health, Labour and Welfare (MHLW) approved VYVDURA for adults with chronic inflammatory demyelinating polyneuropathy. VYVDURA is ...
(ENXTBR:ARGX) plans to present new Phase 3 data for VYVGART and pipeline candidates at the 2026 American Academy of Neurology ...
Multiple sclerosis, a neuroinflammatory disease that affects nearly 3 million people worldwide, causes a loss of myelin, the fatty sheath that covers nerve cells in the brain and spinal cord. Chronic ...
Takeda is making its first foray into rare disease marketing on connected TV (CTV). The Japanese biotech recently launched a video campaign for its chronic inflammatory demyelinating polyneuropathy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results